We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Omrix Biopharmaceuticals (MM) | NASDAQ:OMRI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.99 | 0 | 01:00:00 |
Commission
File Number
|
000-51905
|
|
OMRIX
BIOPHARMACEUTICALS, INC.
|
||
(Exact
name of registrant as specified in its charter)
Omrix
Biopharmaceuticals, Inc.
1120
Avenue of Americas
New
York, New York 10036
(212)
887-6500
|
||
(Address,
including zip code, and telephone number, including area code, of
registrant’s principal executive offices)
Common
Stock, par value $0.01 per share
|
||
(Title
of each class of securities covered by this Form)
None
|
||
(Titles
of all other classes of securities for which a duty to file reports
under
section
13(a) or 15(d)
remains)
|
Rule
12g-4(a)(1)
|
x
|
||
Rule
12g-4(a)(2)
|
o
|
||
Rule
12h-3(b)(1)(i)
|
x
|
||
Rule
12h-3(b)(1)(ii)
|
o
|
||
Rule
15d-6
|
o
|
Date: December
30, 2008
|
By:
|
/s/
James J. Bergin
|
|
Name:
|
James
J. Bergin
|
||
Title:
|
Vice
President
|
1 Year Omrix Biopharmaceuticals (MM) Chart |
1 Month Omrix Biopharmaceuticals (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions